| Literature DB >> 32443849 |
G-Young Van1, Adeola Onasanya1, Jo van Engelen1,2, Oladimeji Oladepo3, Jan Carel Diehl1.
Abstract
Schistosomiasis is one of the Neglected Tropical Diseases that affects over 200 million people worldwide, of which 29 million people in Nigeria. The principal strategy for schistosomiasis in Nigeria is a control and elimination program which comprises a school-based Mass Drug Administration (MDA) with limitations of high re-infection rates and the exclusion of high-risk populations. The World Health Organization (WHO) recommends guided case management of schistosomiasis (diagnostic tests or symptom-based detection plus treatment) at the Primary Health Care (PHC) level to ensure more comprehensive morbidity control. However, these require experienced personnel with sufficient knowledge of symptoms and functioning laboratory equipment. Little is known about where, by whom and how diagnosis is performed at health facilities within the case management of schistosomiasis in Nigeria. Furthermore, there is a paucity of information on patients' health-seeking behaviour from the onset of disease symptoms until a cure is obtained. In this study, we describe both perspectives in Oyo state, Nigeria and address the barriers using adapted health-seeking stages and access framework. The opportunities for improving case management were identified, such as a prevalence study of high-risk groups, community education and screening, enhancing diagnostic capacity at the PHC through point-of-care diagnostics and strengthening the capability of health workers.Entities:
Keywords: Nigeria; access to healthcare; barriers to diagnostics; case management; end-user perspectives; neglected tropical diseases; schistosomiasis
Year: 2020 PMID: 32443849 PMCID: PMC7278006 DOI: 10.3390/diagnostics10050328
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Stakeholder categories and respondents.
| Stakeholder Categories | Respondents | LGA | |
|---|---|---|---|
| 1 | Community members who have experience with schistosomiasis | 6 Parents/Guardians of people who were treated for schistosomiasis | Ibadan North, Akinyele |
| 2 | Stakeholders within community that can impact on the patient decision to access care | 1 Traditional healer | 1 Ibadan North |
| 3 | Stakeholders in the formal health care | 2 Community Health worker | Ibadan North, Akinyele |
| 4 | Stakeholders within Local and State Government | 1 Medical Officer of Health/PHC Coordinator | Ibadan North, Akinyele |
| 5 | Stakeholders in academia | 3 Researchers | University of Ibadan |
1 The community in Akinyele did not have residential traditional healer or PMV.
Figure 1Adapted health-seeking pathway with six stages based on [15,27].
6A Framework of access to healthcare.
| Dimensions | Component | Theme |
|---|---|---|
| Awareness | Communication and information | General health literacy |
| Accessibility | Location | Distribution of, and distance to, health care providers |
| Availability | Supply and demand | Incomplete medical infrastructure |
| Acceptability | Consumer perception | Cultural belief and influence from the community |
| Affordability | Financial and incidental costs | Cost of treatment |
| Adequacy (Accommodation) | Organisation | Mismatch between available information and awareness, knowledge, and education needs |
Figure 2Identified barriers in the case management and diagnosis in 6A Framework. ○ = Barriers from the healthcare seeker perspectives, ● = Barriers from the healthcare provider perspectives.
Barriers categorized in 6A dimensions and the perspectives.
| 6A Dimension | Barriers Identified | HC Seeker | HC Provider |
|---|---|---|---|
| Awareness | T1: Lack of general knowledge on health and schistosomiasis among community (Stage 1) | ✓ 1 | |
| T2: Cultural association and belief about the symptoms (Stage 1) | ✓ | ||
| T3: Trying out self-medication without prescription Take irrelevant medicines on one’s own (Stage 2) | ✓ | ||
| T4: The symptoms are associated with STD which causes hesitation in sharing with others (Stage 3) | ✓ | ||
| T5: Limited access to the right information within the community due to low awareness of schistosomiasis (Stage 4) | ✓ | ||
| Accessibility | T13: Extra steps of movements are required for diagnosis and treatment. | ✓ | |
| T17: Distance to the referral is far (Stage 6) | ✓ | ||
| Availability | T10: Incomplete medical infrastructure to perform diagnosis (Stage 5) | ✓ | |
| T11: Lack of lab scientists and technicians to perform diagnosis (Stage 5) | ✓ | ||
| T12: Incapability to perform the diagnosis with sufficient quality (Stage 5) | ✓ | ||
| Acceptability | T7: Negative attitudes of the health workers may prevent people from accessing the formal health care (Stage 4) | ✓ | |
| T19: Fear of healthcare and uncertainty makes people hesitant to reach referral (Stage 5) | ✓ | ||
| Affordability | T14: The costs incurred for extra steps are patient’s responsibilities. | ✓ | |
| T18: The transportation costs to reach referral are unaffordable (Stage 6) | ✓ | ||
| Adequacy/Accommodation | T6: Going through trial-and-error medications without prescriptions at the PMVs (Stage 4) | ✓ | |
| T8: Knowledge gap of high risk groups of schistosomiasis among the community (Stage 5) | ✓ | ||
| T9: Failure in suspecting the case based on symptoms (Stage 5) | ✓ | ||
| T15: The symptom-based treatments are not always available (Stage 5) | ✓ | ||
| T18: Treatment are given before the test results are available. (Stage 5) | ✓ |
1 Checkmark ✓ indicates from which perspective the barrier is found.